Inventor
STEVEN H. SPERGEL
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
12,240,840Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha202512,157,733Aminotriazolopyridines as kinase inhibitors202412,110,290Triazolopyridinyl compounds as kinase inhibitors202411,884,650Substituted heterocyclic compounds202411,866,414Substituted heterocyclic compounds202411,767,322Triazolopyridinyl compounds as kinase inhibitors202311,440,913Aminoimidazopyridazines as kinase inhibitors202211,299,494Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-a modulators2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (8)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 8 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2025 |